Colgate and the National Dental Association Foundation support the award, which is for $10,000.
UAB researcher to develop medical decision making guide for minority patients with lupus.
A UAB study discovers a pathway used by malignant tumor cells to invade healthy parts of the brain, giving researchers a fresh target for drug discovery.
Saxena’s research aims to make mobile interactions and transactions more simple and secure. His was one of 105 projects funded.
Dr. and Mrs. Robert C. Bourge have helped establish three endowed research funds.
The center will be interdisciplinary and involve faculty leaders from the College of Arts and Sciences and the schools of Business, Medicine and Public Health.
UAB will also enhance patient access to clinical trials and train the next generation of clinicians and scientists through clinical and basic/translational fellowships.
World-renowned scientists search for ways to prevent acute kidney failure, improve management of the disease.
In the UAB lab, sleep-restricted adolescents showed a 50 percent increase in hits or close calls with virtual vehicles when they crossed the street tired.
UAB researchers find differences in polymerase chains thought to be similar, potentially opening new pathways toward cancer drug development.
UAB researchers show long-term efficacy of the first FDA approved drug for vasculitis.
Discovery leads researchers to redouble efforts to design a new class of drugs to treat diabetes.
This unique Creativity is a Decision competition, now in its third year, is open to graduate students, postdoctoral fellows, faculty and staff.
The awards were presented in July during the 2013 STI and AIDS World Congress in Vienna, Austria.
The institutions named in the awards were selected on the basis of their demonstrated strength at promoting careers of young investigators in the areas of obesity, nutrition and statistical science.
The funds are provided by the Mid-South Transdisciplinary Collaborative Center for Health Disparities Research, part of UAB’s Minority Health and Health Disparities Research Center.
Stoll will be recognized during the 2013 American College of Rheumatology/Association of Rheumatology Health Professionals annual meeting in October.
The grant will provide physicians a more targeted approach to treating the most commonly diagnosed form of breast cancer, estrogen receptor positive (ER+).
Shevde-Samant has been elected a member of the Chemo/Dietary Prevention Study Section for the Center for Scientific Review